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Abstract
Sestrins are highly conserved proteins which are induced under environmentally stressful
conditions to adjust the cell’s response to such disturbances. This protein possesses two domains
critical for its dual function in reducing reactive oxygen species (ROS) and regulating the
mTORC1 complex. Sestrins may use diverse transcription factors, such as Nrf2, peroxiredoxin
reductase activity, and a catalytic cysteine to regenerate oxidized species; however this was
confirmed to be through a mechanism likely different than AhpD, for which there was distance
sequence similarity. Furthermore, Sestrins are important regulators of TORC1 and AMPK, which
are crucial energy sensors able to control cellular metabolism under oxidative stress.
Additionally, the role and relative abundance of leucine in relation to the association between
Sestrin, GATOR2, and mTORC1 along with Sestrin2 phosphorylation state is further explored
and connected to obesity and degenerative diseases. Following literature review, residues
Cys125, Leu261, Asp406, Asp407 , were identified to be critical for the aforementioned
functions of Sestrins when confronted with oxidative stresses. The previously established
phosphorylation mutations at position 73, 110, and 254, specifically the mutation of serine to
alanine at position 110 (S110A), were analyzed using ChimeraX to determine effects on
distance change and how this may alter enzymatic functionality.
Background
Sestrins are a family of highly conserved, stress induced proteins that have two primary
functions: reduction of reactive oxygen species and regulation of the rapamycin complex 1
(mTORC1) complex (1). Environmental stressors, such as metal toxicity, air pollution, and so
forth, can cause damage to DNA, lipids, and other macromolecules, resulting in tissue
dysfunction and accelerated aging (2). Sestrins are induced and modulated by such stresses and
can regulate a variety of downstream outputs to coordinate the cell’s response to stress, thus
enabling dynamic regulation through environmental input at both transcriptional and
posttranscriptional levels (2, 3). Furthermore, sestrin proteins also hold critical roles in insulin
sensitivity, glucose and fat metabolism, and redox function in metabolic diseases and aging (3).
There are three main types of Sestrins (Sesn1-3), all of which vary slightly but possess similar
functions. Sesn1 is expressed ubiquitously in pancreatic, kidney, skeletal, lung, and brain tissue,
which becomes activated in a p53 manner under oxidative and irradiation stresses (3). Sesn2 is
activated by DNA damaging oxidative stresses and overnutrition stress in the lung, liver,
adipose, kidney, and pancreatic tissue (2,3). Sesn3 is redundant in relation to Sesn2, but is
associated with the mitochondria, nucleus, and endoplasmic reticulum of the cell (3). In the liver,
Sestrin1 mRNA expression was the greatest, however in all other tissues, Sestrin3 had the
greatest expression (4). In general, cells must regulate many aspects of the cell including insulin
sensitivity, fatty acid metabolism, endoplasmic reticulum (ER) stress, and autophagy (1,2,3).
Under certain conditions like glucose starvation, amino acid deprivation and mitochondrial
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dysfunction, Sestrins are induced as a protective mechanism to help regulate the fluctuating
conditions (2,3). Initially, the upregulation of Sestrins is observed as a defense mechanism in the
tissues under metabolic stress and inflammation or during predisposition stage of metabolic
syndrome, but as stress conditions maintain high levels, the amount of Sestrins is dramatically
suppressed in the nature of disease conditions, observed in type II diabetes, dyslipidemia, colon
cancer development and muscle aging progression (3). Sestrin deficiency was observed to
accelerate several pathways such as mTORC1 activation, redox dysfunction, aging, fat
accumulation, insulin resistance, muscle degeneration, cardiac dysfunction, mitochondrial
pathologies, and tumorigenesis (1, 2).
There are two main domains that support Sestrin function. One has direct oxidoreductase
activity, which supports redox function, while the other domain interacts with the GATOR2
protein complex, which regulates mTORC1 activity (Fig.1) (2,3). Human Sestrin 2 (hSesn2), the
protein of interest, has two structurally similar globular domains that execute these two distinct
functions (5). The N-terminal domain reduces alkyl hydroperoxide radicals through the
helix-turn-helix oxidoreductase motif, while the C-terminal domain has modified this motif to
accommodate for physical interaction with GATOR2 and subsequent inhibition of mTORC1 (5).
By its ability to reduce alkyl hydroperoxide radicals and suppress mTORC1 signaling, Sestrins
act as a link between DNA damage signaling through p53 pathways and control cell signaling
through the mTORC1 complex (2,5).
Although later discussion focuses more heavily on the impact of mTORC1 regulation, it
is still important to acknowledge how the protein is able to reduce reactive oxygen species
(ROS). Some ROS is needed for homeostasis, but excess can cause damage to DNA and
proteins; however, sestrins are able to suppress oxidative damage to the cell through diverse
transcription factors, such as p53, nuclear factor (erythroid-derived 2)-like 2 (Nrf2), AP-1, and
FoxOs (1, 3). Nrf2, a transcription factor that upregulates antioxidant genes including Prx, Srx,
glutathione-S-transferase (GST), and thioredoxin (Trx), targets, binds, and activates Keap1,
which may be inhibited through oxidation of several cysteine residues (1). Furthermore, Sestrin2
promotes ULK1-induced phosphorylation of SQSTM1, a complex which facilitates Keap1
degradation and Nrf2 activation (1). Oxidative stress upregulates Sestrin 2 through the oxidative
stress-inducible transcription factor Nrf2, which in turn, along with AP-1, mediates Sestrin 2 by
immune stress through lipopolysaccharide (LPS) (2). Sestrins along with its inhibitor partner
p62/SQSTM1 are targets of Nrf2, which creates a feedforward loop, strengthening antioxidant
defense (2). This process reduces stress on the damaged mitochondria, improves fat metabolism,
and maintains mitochondrial function in mammalian cells (3). Additionally, the pathway is
important for antioxidant defense against hepatocytes under nutritional and chemical stress (1)
Specific regions in Sestrins share sequence and structure homology with alkyl
hydroperoxidase D (AhpD), which regenerates oxidized bacterial Prxs, ROS, or reactive nitrogen
species (RNS), suggesting the two have similar peroxiredoxin reductase activity. (1, 3, 6). While
AhpD is a disulfide reductase, Sestrin2 is likely a cysteine sulfinyl reductase, regenerating
oxidized Prxs, particularly Cys125 or Tyr127. These residues are critical for the conserved
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proton relay system, and the enzymes use the hydrophobic surroundings to direct peroxidase
activity specifically towards hydrophobic alkyl hydroperoxides and decreasing affinity toward
hydrogen peroxides (1,5,6). HSesn2 reduces alkyl hydroperoxide radicals using cysteine sulfenic
acid as a reaction intermediate single and catalytic cysteine (Cys125), which is reversibly
sulfenylated during its catalytic cycle (5). Although Sestrin2 also has peroxiredoxin reductase
activity and sequence similarity to AhpD, they share one catalytic cysteine present in the NTD
but not the CTD, which suggests sestrins use an entirely different mechanism for amino acid
sensing (6, 1). Ultimately, Sestrins are known to be effective in managing disease and aging by
removing oxidative stress, improving cellular metabolism, and aiding immunity, which is
achieved through their reduction of reactive oxygen species (3).
Another critical function of Sestrins is the stress-dependent regulation of the mechanistic
target of rapamycin complex (mTORC1), which helps regulate cell growth, metabolism,
nutritional effects, and is implicated in human diseases including diabetes, cancer, and aging
(1,6). In fact, upregulation of mTORC1 has been observed to lead to the accelerated development
of several obesity induced and age-related pathologies, such as lipid accumulation, inflammation,
glucose tolerance, insulin resistance, ER stress, mitochondrial dysfunction, protein aggregate
formation, cardiac arrhythmia and muscle degeneration (3). By integrating environmental signals
such as nutrient availability, growth factors, oxygen, and stress, cells can regulate protein
translation, metabolism, cell growth, and nutrient availability through mTORC1 (7, 6). The
mTORC1 complex may inhibit autophagic protein degradation by phosphorylating and
inactivating unc-51-like autophagy-activating kinase 1 (ULK1), the initiating kinase of
autophagy (7). In one study suggesting exercise induces direct interaction between Sestrin2 and
AMPK, Sestrins were directly induced by exercise and its phosphorylation by ULK1 kinase was
observed along with autophagy induction, which improved metabolic parameters, prevented
atrophy, and maintained mitochondrial mass in muscle (3). Thus, AMPK and mTORC1 are
cellular energy sensors that respond in a reciprocal manner to environmental conditions such as
nutrient supply or cellular stress to control metabolism and growth in insulin-sensitive tissues
like skeletal muscle (1, 3). Furthermore, leucine (Leu) levels can reveal important information
about an organism's physiological state in relation to food availability, insulin levels, muscle
mass development, and so forth (6). Sestrin 2, a leucine sensor which connects the concentration
of leucine to an organism’s metabolism and growth rate, when released from a complex by
GATOR2, activates the mTORC1 complex (6). This feat is accomplished when leucine binds
through a single pocket that coordinates its charged functional groups and confers specificity for
the hydrophobic side chain while amino acids regulate the state of GTP/GAP dependent Rag
proteins involved in the regulation pathway (6). Although Sestrins appear to be the primary
leucine sensor in the mTORC1 pathway, it contains no sequence similarity with known amino
acid binding domains (6).
In fact, when environmental stresses cause mitochondrial dysfunction, Sestrins may
upregulate autophagy through AMPK-activated protein kinase and inhibition of mTORC1 (1,2,
4). AMPK is the crucial downstream target of Sestrin controlling metabolic homeostasis with
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the AMPK/TSC2 pathways being necessary for controlling tissue growth and for managing
age-associated pathways (1). Thus, the mechanism of regulation for the mTORC1 complex is
stress-dependent and can improve insulin sensitivity, prevent excessive lipid accumulation, and
alleviate endoplasmic reticulum stress (1,3, 7). Sestrins are able to inhibit two essential GTPases,
Rheb and Rag A/B, the former a monomeric GTP-binding protein and the latter functioning as
obligate heterodimers of Rag A/B bound to Rag C/D; however, both help localization to the
lysosomal surface, which is the site of mTORC1 regulation (1, 7, 8). Amino acids promote
mTORC1 movement to the lysosomal surface through a Rag dependent process, where
GTP-bound Rheb becomes involved and stimulates its kinase activity, thereby implicating
Sestrins in the amino acid-dependent control of mTORC1 (1,6, 8). Nevertheless, Sestrins do not
directly control RagA/B activity on the lysosomal membrane (1).
Sestrins inhibit RagA/B-dependent mTORC1 activation through modulation of the
GATOR complexes, likely binding to GATOR2, liberating GATOR1 using GATOR2-mediated
inhibition, and thereby promoting the RagA/B-inhibiting GAP activity of GATOR1 (1, 5)
(Fig.1). Neither C or N terminal domains (NTD, CTD) are bound to GATOR2, but when
expressed together, they bind tightly to each other and to GATOR2, thus implying both are
required for GATOR2 interactions, Leu sensing capabilities, and mTORC1 activation (1,6).
Under unstressed conditions, Sestrin expression is low, which allows GATOR1 and GATOR2 to
form a super complex (1,7). The mTORC1 complex along with Rag A+B is activated, which
then allows Rag C+D to localize the mTORC1 complex to the lysosomal membrane (1,7).
Growth factors help GTP loading by driving the GAP factor of Rheb off of the lysosomal surface
whereafter the GTP-loaded Rheb then activates phosphorylation activity of the complex (1, 3, 8).
Under high stress conditions, Sestrins are upregulated and bind to GATOR2, which then frees the
GATOR1 complex to have GAP activity on RagA+B, thus inactivating them and preventing Rag
C+D from localizing the complex (1, 3, 8). Importantly, the Sestrin-GATOR2 interaction
activates AMPK, resulting in the GDP-loaded form of Rheb and the phosphorylation of Raptor, a
regulatory component of mTORC1, both of which work to inhibit complex activity (1, 3, 5, 8).
While glutamine starvation recognition is one valuable function of Sestrins, the leucine
sensing mechanisms are highly important to the mTORC regulation function of hSesn2 proteins
(6). Leucine impacts many aspects of health including satiety, insulin secretion, and skeletal
muscle anabolism, and dietary leucine affects physiology because the liver cannot metabolize
leucine, so its levels fluctuate in the blood (8, 4). Leucine levels can reveal important information
about an organism's physiological state, such as food availability, insulin levels, muscle mass
development, and so forth, but the effect of leucine on hSesn2 is dependent on biological
contexts, for instance, amino acid concentrations being higher due to presence of transporters (1,
6). While Sestrins may bind to hydrophobic amino acids, such as isoleucine, valine, and
methionine, they bind with lower binding affinity when compared to leucine (1). The idea that
leucine is physiologically relevant is observed in one study when leucine disrupts the
GATOR2-Sestrin 2 interaction by binding to Sestrin 2 (kd = 20µM) with an affinity equal to half
the leucine concentration that maximally activates mTORC1 (2, 6, 8). Typically, leucine binds
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through a single pocket as previously discussed, but when the affinity for leucine was decreased
by deepening the pocket, this resulted in decreased binding and required more leucine for
dissociation from GATOR2 (1, 2, 6). This suggests that affinity of Sestrins for leucine is a major
determinant of the sensitivity of the mTORC1 pathway to leucine in human cells, which varies
among tissue types (1, 6). Furthermore, Sestrins must interact with GATOR2 for mTORC1 to
sense an absence of leucine, since expression of Sestrin2 mutations that did not sufficiently bind
Leu resulted in inhibition of the signaling pathway, causing leucine insensitivity in the mTORC1
pathway, and decreased localization to the lysosome in the presence of leucine (8). Ultimately,
hSesn2 cannot inhibit mTORC1 in the presence of leucine because leucine binding prohibits
hSesn2 from interacting with its effector, GATOR2; however, hSesn2 must interact with
GATOR2 for mTORC1 to sense an absence of leucine (1, 8). Nevertheless, Sestrins have several
properties that are consistent with it being a leucine sensor for the mTORC1 pathway, one of
which being that it binds leucine at affinity is consistent with the concentrations at which leucine
is sensed (1, 8). Overall, Sestrin mutants that do not bind leucine cannot signal the presence of
leucine to mTORC1 and the loss of Sestrin2 and its homologs renders the mTORC1 pathway
insensitive to the absence of leucine (8).
Interestingly, Sestrin1 is expressed at approximately three times the level of GATOR2,
with one potential explanation for the apparent lackluster effect of abnormal Sestrin expression
on leucine-induced mTORC1 activation in muscle suggesting that the amount of endogenous
Sestrin is sufficient to sequester all of the GATOR2 complex, and increasing Sestrin expression
has no additional repressive effect (4, 8). Additionally, leucine might not only alter
Sestrin-GATOR2 interaction by directly binding to Sestrin, but also by altering Sestrin
phosphorylation state (1,2, 4). In one study, Sestrin2 phosphorylation was enhanced in cells
deprived of leucine, and readdition of the amino acid to leucine-deprived cells rapidly caused
Sestrin dephosphorylation (4). When deprived of leucine, UKL1 phosphorylates Sestrin2, which
affects leucine binding and mTORC1 regulating functions of Sestrin2 and Sestrin2/GATOR2
binding (1, 4). Furthermore, Sestrin 2 can increase the power of UKL1 phosphorylation and
degradation of SQSTM1, which is another mTORC1 regulator that may also be implicated in
amino-acid sensing (1, 2, 7). It is also observed that maximum mTORC1 activation occurs at a
lower Leu concentration in the muscle than in the liver, which may be explained by the greater
sensitivity of mTORC1 to leucine-induced activation in skeletal muscle due to relative Sestrin1
expression being significantly greater than Sestrin2 in muscle (4, 7). The liver is capable of
responding to a wide range of leucine levels because of relatively equal expression of Sestrins 1
and 2 and their disparate affinities for leucine (4). Still, leucine administration activated
mTORC1 regardless of which Sestrins type was expressed (4). Overall, leucine promotes
dissociation of the Sestrin1-GATOR2 complex, which activates the mTORC1 complex (6, 7).
When a system undergoes amino acid deprivation, GCN2 up-regulates ATF4, which is
critical for increasing nonessential amino acid synthesis, to induce expression of Sestrin2, which
represses mTORC1 by blocking its lysosomal localization (7). GCN2–ATF4-dependent Sestrin2
induction and mTORC1 suppression are general consequences of amino acid depletion and are
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not caused by the absence of a specific amino acid, although Sestrin2 is required for inhibiting
the mTORC1 complex under amino acid depletion conditions (7).
There are several residues that are important for Leucine sensing and GATOR2 binding
with Sestrin 2. In one study, mutating the highly conserved and charged residues Asp406 and
Asp407 near the leucine binding site eliminated GATOR2 association of Sestrin2, although no
effect in leucine binding was observed (1). In one study, mutations in Asp406 and Asp407 (the
DD motif) abolished both AMPK-activating and mTORC1-inhibiting functions of hSesn2,
therefore indicating the importance of the DD motif as a key protein-protein interaction site in
GATOR2 and Sestrin signaling (1, 5). The DD motif in the helix–loop region of Sesn-C proved
critical for physical interaction with the GATOR2 complex, regulation of GAP activity towards
Rags, and subsequent modulation of mTORC1 signaling (3, 5). Sestrin 2 binds Leu through a
single pocket formed by the helices C2, C3, and C77 in the CTD, where the highly conserved,
charged residues Glu451 and Arg390 positioned on either side of the pocket stabilize the leucine
through salt bridges with free amine and carboxyl groups (1). The helix L1 in the linker domain
then packs against the side of the pocket through Leu261, confirming Leu261 and Glu451 as
critical residues for Leu binding (1, 3). For instance, in one study, mutating Glu451or Arg390
disrupted normal interactions of interacting with amino acids containing free amine and carboxyl
groups and resulted in the loss of leucine binding abilities, thus resulting in Sestrins remaining
constitutively bound to GATOR2, even in the presence of leucine (1). Furthermore, there is a
hydrophobic pocket containing a chain of Van-Der Waals interactions with Leu389, Trp444, and
Phe447, with any substitution of a charged residue resulting in a loss of Leu sensing capabilities
(1). Nevertheless there are many exclusions since large residues clash with Trp444 in pocket
floor, small molecules will fail to make sufficient Van Der Waals interactions, and the
hydrophobic pocket excludes all charged or polar amino acids (1). Thus, only leucine and the
structurally similar amino acids, such as isoleucine and methionine interact properly (1). Finally,
there is a lid-latch mechanism for leucine binding by Sestrin 2 where the “lid” refers to the
helices C2 and C3 that enclose leucine into the structure (1). In one study, mutating Thr374
resulted in constitutive interaction with GATOR2, thereby interrupting the “lid” locking
mechanism and resulting in no leucine binding (1). It was also observed that Tyr374 forms a
tight hydrogen bond with His86, both highly conserved residues, which acts as the latching
mechanism, therefore indicating that this interdomain contact was critical for Sestrin 2 leucine
binding (1).
Methods
Selection of Chimera structures.
Previously existing X-ray crystallography technology was used to construct structures,
which were made available through the UCSF Chimera software (9, 10). Four structures were
considered for study, but only three were acceptable to test mutation effects on distance changes
to significant residues. The model 6NOM (9), showed Sestrin2 complexed with NV-0005138, the
model 5CUF (1, 5), showed the native structure of hSesn2, and the model 5T0N (11), showed the
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pseudo-apo structure of hSesn2. One model, 5DJ4 (6) was omitted because it displayed trends in
distance changes opposite to those of the other three models, indicating that distance change
patterns may be altered when the protein is already bound to leucine.
Sequence Analysis of hSesn2 with Chimera structures and AhpD.
To begin, the sequence of hSesn2 was obtained using the NCBI database and compared to
the aforementioned structures 6NOM, 5CUF, and 5T0N. Each comparison revealed high
sequence similarity (97-99%), indicating reliability in the models for measuring mutation
induced distance changes between residues. Additionally, in order to further investigate a claim
suggesting sequence similarity between human Sestrin and AhpD (an alkyl hydroperoxidase) and
thus similarity in how they execute their function, a comparison between hSesn2 and AhpD
N-terminus region was made using the National Center for Biotechnology Information’s Basic
Local Alignment Search Tool (NCBI’s BLAST) and Mitofates.
Selection of residues through literature review.
Four specific residues were chosen so distances between the phosphorylation mutation
sites and the selected residues may be measured to determine if there is a significant change in
distance when mutations occur. The chosen residues included Leu261, for its importance in
leucine binding, the DD motif (Asp406 and Asp407), for their importance in Sestrin2 interaction
with GATOR2 complex, and Cys125, for its involvement in redox function. These residues were
chosen after analysis of appropriate literature, which permitted agreement in which residues were
critical in carrying out Sestrin function, such as leucine binding or reduction of alkyl
hydroperoxide radicals.
Measurement of residue distances and statistical treatment of data.
Since previous Ro laboratory groups had established mutation sites of hSestrin2
phosphorylated by ULK1 (3), the ULK1 phosphorylation mutation site Ser110 was selected for
specific study since the mitochondrial translocation mutation sites were truncated in all Chimera
models. This site was then mutated to S110A using the rotamer function of the Chimera X
software, which may impact leucine binding and mTORC1 regulation (9,10). A position on the
hydroxyl group of the serine was selected so that multiple measurements may be obtained from
the wildtype residue to the important residues selected via literature review. To obtain
comparative measurements with the transformation to the S110A mutant, distances were
measured from the methyl group side chain to the same points on the selected residues that were
used for the wildtype measurements. All measurements were obtained using the distance tool
function available in Chimera X and quantified in Angstroms (9, 10). After measuring distances
between wild type and mutated versions, statistical analysis was performed using a paired t-test
with a 95% confidence interval and p-values of 0.1351, 0.2057, 0.2123, and 0.0171 for Leu261,
Asp406, Asp407, and Cys125 respectively, which determined significance (Supplemental Table
2).
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Results
Sequence alignment
In regards to the sequence comparison between hSesn2 and AhpD, no long conserved
region was observed, which suggests little impact on function. Additional literary information
was confirmed with the alignment of the cysteine at position 125. The two share distant sequence
similarity, but a Cys125 mutation in Sestrin, corresponding to catalytic cysteine in AphD,
prevented setstrin from protecting against oxidative stress, thus confirming the importance of
Cys125 in redox function. Furthermore, the high percentage in sequence overlap between the
wildtype hSesn2 and the chosen Chimera structures (Fig.4) suggests that the Chimera structures
are sound and produce reliable distance collection and data comparison to hSesn2, which is the
protein of interest.
Mitochondrial Mutations in ChimeraX
Previous laboratory groups were able to construct mutant variations of the protein, so
initial efforts focused on mitochondrial mutations R17Q and R38Q, which impact the redox
function of Sestrins. The Chimera software was used to study the following sestrin models:
6N0M, 5DJ4, 5CUF, and 5T0N (Fig.3). In all observed structures, no changes were observed due
to the mutation site itself, which was located in the truncated NTD region in the models likely
due to its critical function and conserved nature.
Effect of Mutations on Distance
Mutations were made from serine to alanine (Fig.5) and measurements were made
between selected residues and compared within the same Chimera structure (Fig.6). In distance
measurements, an average distance decrease was observed across all structures at 1.212Å for
Leu261, 1.051Å for Asp406, 1.532Å for Asp407, and 0.893Å for Cys125 (Table 1). There was
no significance in mutating S110A for residues Leu261, Asp406, and Asp407, however there
was significance for Cys125 (Table 4, Fig. 7).
Discussion
Using data obtained from dry experimentation by analyzing X-ray crystallography
structures through the UCSF Chimera software, effects of various mutations on the protein’s
structure were able to be observed. To begin, a comparison between hSesn2 and AhpD
N-terminus region was made, including residues 1-62, and although no long conserved region
was observed, there may be certain amino acids that are critical in cleaving functions. For
example, since arginine(R) at position 33 was not conserved between sequences, mutating to
glutamine(Q) likely does not affect the functionality of Hsesn2. The two share distant sequence
similarity, but a Cys125 mutation in Sestrin, corresponding to catalytic cysteine in AphD,
prevented setstrin from protecting against oxidative stress, thus confirming the importance of
Cys125 in redox function. After determining the truncated nature of the mitochondrial mutations,
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phosphorylation mutations, S73A, S110A, and S254A were studied, since they may impact
leucine binding and mTORC1 regulation. After measuring distances between wild type and
selected residues (D406, D407, C125, L261) of mutated models, statistical analysis was
performed using a t-test (Table 4, Supplemental Table 2), which determined significance. There
was no significance in mutating S110A for residues Leu261, Asp406, and Asp407, however
there was significance for Cys125. In the future, double mutations of S110A and S73A may be
analyzed to determine potential significant changes in distance, and therefore changes in
function, specifically in redox function given the effect of the mutation on the distance to
catalytic residue Cys125. Furthermore, future experimentation may include examining distances
between mutation sites and residues Glu451 and Arg390, for their role in leucine sensing, along
with Leu389, Trp444, and Phe447, which are important for the previously discussed “lid
latching” leucine binding mechanism.
Through the aforementioned functions of redox reduction and mTORC1 regulation,
Sestrins are useful in dealing with a variety of illnesses, including cancer. Chronic
hyperactivation of mTORC1 is one of the hallmarks of tumor proliferation and growth as cancer
cells rapidly synthesize proteins, lipids and cellular components in response to metabolic
dysregulation, hypoxic environment and genetic mutation stresses (4). Furthermore, chronic
stress-induced inactivation of the p53 target triggers Sestrins to promote the outgrowth of cancer
cells, thus implying Sestrins likely have a tumor suppressor function through downstream
regulation by p53 (4). On the contrary, because Sestrins can activate autophagy and reduce ROS
in the hypoxic cancer microenvironment, some studies hypothesize that the proteins promote
cancer cell proliferation and growth in nutrient-deficient or hypoxic conditions (4).
Nevertheless, some researchers propose that by replacing existing treatments with sestrin-based
therapies, this may benefit the safety of the patient and increase efficiency of treatment, although
additional research is required (4).
Sestrins also play a critical role in degenerative and obesity related diseases. Primarily in
Western cultures, there is excessive consumption of fat and sugar combined with sedentary
lifestyle, which causes an exponential increase in the number of patients with obesity and
metabolic diseases such as diabetes, cardiovascular disease, and cancer (4). Regular physical
exercise benefits human health by protecting humans against obesity and metabolic dysfunctions
including insulin resistance, glucose intolerance and galactose malabsorption (4). In fact,
hyperactivation of mTORC1 is one of the underlying mechanisms causing insulin resistance,
lipid accumulation, ER stress, defective autophagy function, and mitochondrial dysfunction (4).
Skeletal muscle is around 40% of lean body mass, thereby playing a critical role in maintaining
protein homeostasis, and in skeletal muscles in particular, Sestrin1 has greater prevalence and a
higher leuciene affinity compared to Sestrin3 and Sestrin2 (4). In one study, leucine itself was
observed to stimulate protein synthesis to the same level as a complete mixture of amino acids
(4). It is proposed that muscle mass is inversely proportional to surviving pathogenic disease and
chronic illness, along with sepsis, acquired immunodeficiency syndrome, sarcopenia, and
cachexia (4). These illnesses are so damaging because they are associated with decreased activity
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and appetite, which leads to loss of muscle mass, further increasing the individual’s susceptibility
(4). Interestingly, Sestrin 1 expression increased following an acute bout of resistance exercise,
therefore implying that resistance exercise may enhance the stimulatory effect of amino acids on
muscle protein synthesis (4). Ultimately, understanding the role of Sestrins in leucine sensing
and regulation of mTORC1 is crucial for furthering research on Sestrin implication in obesity
related and degenerative diseases. The long-term goals of potential Sestrin based treatment
include less distress for the patient, more efficient and possibly less invasive treatment options,
and lower hospital costs for patients.
Finally, it is important to mention limitations surrounding data collection and analysis.
Due to the restricted amount of models available, this severely limited the sample amount, which
could limit the generalizability of the findings. In fact, one model, 5DJ4, delivered unusual data
potentially because it was a leucine bound model, which may account for the abnormal deviation
in measurements; nevertheless, measurements obtained from this structure were not included
when analyzing significance in distance change. Additionally, the theory that changes in
distances may result in loss or alteration of function is a direct method; however, future
experimentations should confirm mutation effects on sestrin functionality through various
testing, for instance Western blotting to measure expression levels in various tissues. Further,
distances may be altered by mutations interacting with other structures, interrupting autophagy
activity, or complexing with other molecules, which could alter interpretation of the data.
Nevertheless, Sestrins provide valuable insight to environmental stress-response in humans and
serve as a point of interest for future treatment for aging, obesity, and degenerative diseases.
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Tables
Table 1
Distances between mutation site (S110/S110A) to selected residues obtained from Chimera
structures 5T0N, 6NOM, and 5CUF
5T0N

6NOM

5CUF

Cys125 (S110)

21.133

20.566

21.063

Cys125 (S110A)

20.042

19.884

20.156

Leu261 (S110)

46.524

46.400

46.833

Leu261 (S110A)

45.887

45.616

44.648

Asp406 (S110)

45.716

44.473

45.203

Asp406 (S110A)

44.585

42.479

45.174

Asp407 (S110)

47.838

47.463

45.771

Asp407 (S110A)

46.796

47.05

45.693

Table 2
Average and standard deviation for S110 compiled from all Chimera structures.
Leu261

Asp406

Asp407

Cys125

Average

45.586Å

45.131Å

47.024Å

20.921Å

Standard
Deviation

0.2230

0.6246

1.012

0.252

Table 3
Average and standard deviation for S110A compiled from all Chimera structures.
Leu261

Asp406

Asp407

Cys125

Average

45.384Å

44.079Å

46.513Å

20.027Å

Standard
Deviation

0.6514

1.417

0.7214

0.112

Table 4
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T-values determined from paired t-test of S110 and S110A data obtained from all Chimera
structures
Leu261

Asp406

Asp407

Cys125

t-value

2.4365

1.8488

1.1084

7.5536

Significance

Insignificant

Insignificant

Insignificant

Significant

Supplemental Table 1
Distance(Å) from Ser110/Ser110A to residues of interested from omitted structure 5DJ4
Leu261

Asp406

Asp407

Cys125

Ser110

42.123Å

44.418Å

45.921Å

NA

Ser110A

44.104Å

44.569Å

45.951Å

NA

Asp406

Asp407

Cys125

Mean Difference 1.2020Å

1.01533Å

0.5110Å

0.89333Å

P-value

0.1351

0.2057

0.2123

0.0171

95% Confidence
Interval

-0.9262 to
3.32462

-1.39534 to
3.49801

-0.70477 to
1.72677

0.38448 to
1.40219

Standard Error
of Difference

0.493

0.569

0.283

0.118

Supplemental Table 2
Additional statistical values for paired t-test (df=2)
Leu261
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Figures

Fig.1 Human Sestrin2 and its oxidoreductase binding site, GATOR2 interaction surface, and
leucine binding site using Chimera structures 5CUF and 5DJ4
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Fig.2 Sestrin mediated regulation of mTORC1 under unstressed (A) and stressed (B) conditions

Fig.3 Chimera structures used to obtain residue distance measurements
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Fig.4 Sequence alignment sample between 5CUF(top) and wild-type hsesn2 (bottom)

Fig.5 Ser110 (left) mutated to S110A (right) from Chimera structure 5CUF
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Fig.6 Distance to Leu261 from S110 (left) and S110A (right) using Chimera structure 6NOM

18

Fig.7 Distance measurements for each Chimera structure from the mutation site to the selected
residue

19

Fig.8 Table used for t-test comparison and to determine significance
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